Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.22.2.2
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Accounts payable:    
Clinical and regulatory expenses $ 537 $ 534
Professional fees 615 477
Selling expenses 1,001 932
Manufacturing costs 245 378
Non-employee board member compensation 417 136
Other vendors 192 262
Total accounts payable 3,007 2,719
Accrued interest payable, related parties 227 91
Accrued interest payable 1,288 579
Accrued expenses:    
Payroll expenses 1,303 1,097
Government rebates and other rebates 4,520 4,371
Other accrued expenses 373 332
Total accrued expenses 6,196 5,800
Total accounts payable and accrued expenses $ 10,718 $ 9,189